Ascending Investigators
Anders Bach
Targeting oxidative stress in the brain with Keap1 prodrugs cleavable by reactive oxygen species
Associate Professor
University of Copenhagen
Associate professor, Department of Drug Design and Pharmacology, University of Copenhagen, has received a Lundbeck Foundation Ascending Investigators research grant worth DKK 5,000,000.
The aim of his project is to develop a novel concept for the design of drugs for diseases of the central nervous system, including medicines for multiple sclerosis.
